Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Mcn Trading Range Narrows Breakout Expected 20260401 1 How Does Solesence Slsn Stock Perform In Rallies Price At 1.26 Up 4.55 20260408 Is Gitlab Gtlb Stock Priced Correctly Price At 23.71 Up 2.44 20260408 Is Kingsoft Kc Stock Losing Momentum Price At 13.59 Down 0.80 20260406 First FCBC Stock Is It Overpriced Q4 2025 Profit Exceeds Views XZO Exzeo Group Inc shares rise 658 percent after Q4 2025 earnings deliver 42 percent EPS surprise over estimates Is RingCentral RNG stock a good buy at todays price 015 20260418 Intel Corporation INTC Hits AllTime High on Robust Q1 2026 Revenue Growth and Positive AIFueled Forward Guidance SE Sea drops 212 after Q4 2025 EPS narrowly misses consensus analyst earnings estimates Palo Alto Networks PANW Fundamental Strength Supports Wall Street Bullish Consensus Amid Peers Underperformance RUSHA Rush Q1 earnings beat Wall Street estimates but shares dip despite EPS upside Is International Seaways INSW stock volatile Q4 2025 Earnings Beat Estimates What merger control K Wave KWM ConocoPhillips COP Q1 2026 Earnings Highlight Geopolitical Resilience and Material Valuation Upside Amid Middle East Tensions FWDI Forward Industries falls 412 after Q3 2024 earnings report posts a negative 034 earnings per share SafeHaven Yen and Swiss Franc Rally as DeepSeek AI Disruption Hits US Tech Stocks SunOpta STKL Q4 2025 Earnings Beat Revenue NA EPS 006 Mueller Industries MLI Q1 2026 Earnings Surprise EPS 187 Up Significant Heidmar HMR Climbs 1352 Resistance at 104 in Focus 20260514 Why Chasing Returns Could Be a Costly Mistake for LongTerm Investors MettlerToledo International MTD Stock Down 224 Support Test at 99823 20260519 Legal General Group Highlights 5B Returns and Streamlined Strategy at 2026 AGM AEye LIDR Q1 2026 Miss What Went Wrong Prenetics PRENW Stock Analysis 2067 Loss Key Levels 20260520 Spain Blocks Polymarket and Kalshi Amid Gambling License Investigation Analyst Report Highlights Walmarts Resilience Amid Changing Retail Landscape Waymo Expands Robotaxi Pause in Five US Cities After Navigating Flooded Roads China Emerges as Leading Competitor in Humanoid Robot Workforce Integration Says Tesla CEO Prediction Markets Face State Crackdown Amid Federal Regulatory TugofWar Charter Communications to Acquire Liberty Broadband in Enhanced Buyout Deal FrancoNevada Q1 2026 Earnings EPS Beats Estimates by 137 Shares Edge Higher Capri Holdings Q1 2026 Earnings EPS Beat Bolsters Investor Sentiment Despite Revenue Uncertainty Innventure Inc Q1 2026 Earnings Narrower Loss Exceeds Expectations Amid Limited Revenue Disclosure Valero Energy Q1 2026 Earnings Strong Refining Margins Drive 32 EPS Beat Despite Weaker Stock Reaction TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines McKinley Acquisition Corporation Rights MKLYR Surges 40 Rights Trading at 014 COPT Defense Properties Edges Higher Amid Steady Demand for DefenseOriented Real Estate CDP Hercules Capital Notes HCXY Slight Decline Amid Steady FixedIncome Trading First Seacoast Bancorp FSEA Edges Higher as Stock Holds Above Key Support Riley Exploration Permian Faces Headwinds as Shares Decline Nearly 6 REPX Technicals Test Key Support Cemtrex Inc CETX Holds Above 088 Support After Modest Gains European Firms Retain China Manufacturing Despite EU DeRisking Efforts ALTG Q1 2026 Earnings EPS Misses Estimates Shares Decline 31 Church of Latterday Saints Investment Arm Holds Significant Positions in Tech Giants NVDA and MSFT TechEnabled Woodworking Tools Reshaping the Industry Landscape Atlantic Am AAME Q2 2025 Earnings EPS 007 In Line with Estimates Royal Observatory Director Warns Instant AI Answers May Undermine Human Intelligence and Market Value of Knowledge Am Vanguard AVD Q3 2025 Disappoints EPS 043 Below 008 Views SP 500 and Nasdaq Decline as Oil Prices Climb on Renewed Iran Peace Talk Uncertainties Scholar Rock SRRK Q1 2026 Earnings Prerevenue Biotech Misses Estimates as Clinical Pipeline Progress Remains in Focus